18

Mar

2021

16:00

GMT

Webinar

A Peek into the Future – Repair and Replacement of the Mitral and Tricuspid Valves with the Edwards Portfolio

Overview


This webinar, at 5pm CET / 4pm GMT, will bring together an internationally-respected faculty to review the PASCAL platform focusing on the recently CE mark approved PASCAL Ace implant system for the treatment of mitral and tricuspid regurgitation.

Through a combination of case presentations, discussion, and a live case procedure from Heidelberg University Hospital, the theory- and practical-based agenda has been formulated to best support everyday practice and enhance patient outcomes.

Pipeline products for tricuspid transcatheter replacement from Edwards Lifesciences will be shown and briefly discussed.

Faculty:


Nicolas M Van Mieghem

Nicolas M Van Mieghem


Peter Lüdike

Peter Lüdike


Philipp Lurz

Philipp Lurz


Ralph Stephan von Bardeleben

Ralph Stephan von Bardeleben


Philip Raake

Philip Raake

This webinar is supported by:

Agenda

17:00 CET

Welcome
- Nicolas van Mieghem

17:02 CET

Treatment of Mitral and Tricuspid Regurgitation – An Update
- Nicolas van Mieghem

17:06 CET

The PASCAL Platform: Successfully and Confidently Treat MR
- Peter Lüdike

17:16 CET

Discussion
- All

17:20 CET

PASCAL Ace – the Therapy to Successfully Treat TR
- Philipp Lurz

17:30 CET

Discussion
- All

17:34 CET

Looking into the Future – Valve Replacement with the EVOQUE System
- Ralph Stephan von Bardeleben

17:40 CET

Discussion
- All

17:44 CET

Live Case - PASCAL Ace Implant System for the Treatment of TR from the University Hospital of Heidelberg, Germany
- Philip Raake

18:24 CET

Session Evaluation and Key Learnings
- Nicolas van Mieghem

LEARNING OBJECTIVES

  • To show latest evidence on what is new in mitral and/or tricuspid valve disease
  • Appreciate the clinical impact of the PASCAL platform for MR and TR treatment
  • To participate in a step-by-step LIVE demonstration of percutaneous tricuspid leaflet repair with PASCAL Ace implant system
  • Discover the potential of transcatheter replacement technologies for the treatment of TR

AUDIENCE

  • Interventional Cardiologists
  • General Cardiologists
  • Heart Failure Specialists
  • Echocardiographers
  • Nurses

Faculty Biographies


Nicolas M Van Mieghem

Nicolas M Van Mieghem

Prof Nicolas Maria Van Mieghem is an Interventional cardiologist at Thoraxcenter, Erasmus MC, Rotterdam, NL decided to pursue a career that would help others. “I enjoy the feeling of being able to help someone or do something important for them". His father was a general cardiologist and one of his biggest influences early in his career.

Prof Van Mieghem initially intended to train as a cardiac surgeon but decided to specialise in interventional cardiology instead, following advice from a mentor. This decision was cemented when he read the first-in-human case report of transcatheter aortic valve implantation (TAVI) in Circulation by Alain Cribier in 2002. Prof Van Mieghem believes that great cardiologist genuinely cares for their patients. He names Gary Roubin, Dr Manu Malbrain and Professor Patrick Serruys among his mentors. 

His current research focuses on cerebral embolic protection during TAVI and the search for improved large bore closure devices. He works actively in expanding TAVI indications, most notably TAVI as a means to further unload the left ventricle in heart failure patients with moderate aortic stenosis (the TAVR UNLOAD trial). Prof Van Mieghem is also involved in the development and dispersion of mechanical circulatory support (MCS) devices as well as transcatheter mitral and tricuspid repair techniques. In terms of imaging and preprocedural planning, his research has covered computed tomography (CT)-derived 3D modelling and printing.

As well as his involvement in percutaneous coronary interventions and structural heart programs, he has published and co-authored over 350 scientific papers in peer-reviewed journals. Professor Van Mieghem is a principal investigator and steering committee member in multiple ongoing international trials, evaluating various coronary and transcatheter valve technologies. He is a Fellow of the European Society of Cardiology (FESC) and is currently Medical Director of the department of Interventional cardiology at the Thorax Centre.

 Prof Van Mieghem is on the ICR3 Editorial Board.

 

View full profile

Peter Lüdike

Peter Lüdike

Prof Peter Lüdike is Senior Physician of the Heart Failure and Intensive Care section in the Department of Cardiology and Vascular Medicine at the West German Heart and Vascular Center, University Hospital Essen. He achieved Venia legendi for internal medicine in 2018 and was appointed as Full Professor for heart failure in 2020. His research interests include intensive care medicine, emergency medicine, heart failure, mitral valve disease and the role of macrophage migration inhibitory factor in the development of ischaemic heart disease.

View full profile

Philipp Lurz

Philipp Lurz

Prof Philipp Lurz is Deputy Head of the Department at Heart Center Leipzig, Germany, a position he has held since 2018. Previously, Prof Lurz was a Clinical Research Fellow at Great Ormond Street Hospital for Children NHS Foundation Trust. He completed his education at the University of Leipzig, and is a member of the German Society of Cardiology. Philipp is widely published in leading international peer-reviewed journals.

View full profile

Ralph Stephan von Bardeleben

Ralph Stephan von Bardeleben

Prof Ralph Stephan von Bardeleben is the Head of the Centre of Structural Heart Disease Interventions and the Heart Valve Centre in Mainz, Germany. 

Prof Bardeleben is Past-President of the German working group on Echocardiography of the German Society of Cardiology and a member of several medical societies. He serves on the Clinical Program commission and at your region program of the ESC and is a reviewer for several peer-reviewed journals. Newly elected co-editor-in-chief of Echocardiography Journal.

He participates as PI, steering committee member and core laboratory in several medical device trials, including a German Federal Institute for Drugs and Medical Devices (BfArM)-approved first- or early-in-human medical device implant trials.

View full profile

Philip Raake

Philip Raake

Prof Philip Raake is a senior physician who leads the HFU centre at the Department of Cardiology at Heidelberg University Hospital. He also runs the Interventional HF programme.

Prof Philip Raake attended medical school at the Ludwig-Maximilians University in Munich. Between 2006 and 2008, Prof Raake worked at the Center for Translational Medicine, under the direction of Prof Walter Koch, at the Thomas Jefferson University, Philadelphia.

In 2008 Prof Raake returned to Germany, where his established the first university Advanced Heart Failure Unit in Germany focusing on optimised care in advanced HF. He has authored or co-authored several papers in leading peer-reviewed journals on HF basic molecular mechanisms, and clinical aspects of advanced HF. He serves on several working groups for the German Society for Cardiology and the German Federal Physicians Association.

View full profile